•  
  •  
 

Authors

Liv Baldasare

Abstract

This review article discusses different treatment approaches for glioblastoma multiforme tumors. The lethal characteristics of the glioblastoma are defined in depth. Risk factors, such as career firefighting, are explored, and the effect socioeconomic status has on prognosis is evaluated. The endocannabinoid system is defined, and its role in lowering rates of proliferation for glioblastoma tumors is discussed. Immunotherapies for glioblastomas are reviewed. Specifically, the current clinical trials on an Australian physician who is battling his own glioblastoma are discussed. Importantly, this physician is using his own treatment regimen and has been having clear scans for 18 months.


Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.